Evidence map›Paper›PMID 25025494›Full record

ArticlePloS one2014

Early activation of STAT3 regulates reactive astrogliosis induced by diverse forms of neurotoxicity.

James P O'Callaghan, Kimberly A Kelly, Reyna L VanGilder, Michael V Sofroniew, Diane B Miller

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 92 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
92citing papers in PubMed, 1 pooled it
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

92 citing papers in PubMed, 1 synthesis or guideline pooled it, 138 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Application of anFrontiers in cellular neuroscience · 2024
    Article

32 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

James P O'CallaghanCenters for Disease Control and Prevention, National Institute for Occupational Safety and Health, Morgantown, West Virginia, United States of America.
Kimberly A KellyCenters for Disease Control and Prevention, National Institute for Occupational Safety and Health, Morgantown, West Virginia, United States of America.
Reyna L VanGilderSchool of Pharmacy, West Virginia University, Morgantown, West Virginia, United States of America.
Michael V SofroniewDavid Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America.
Diane B MillerCenters for Disease Control and Prevention, National Institute for Occupational Safety and Health, Morgantown, West Virginia, United States of America.
National Institute for Occupational Safety and Health · USCenters for Disease Control and Prevention · USUniversity of California, Los Angeles · USWest Virginia University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Astrogliosis, a cellular response characterized by astrocytic hypertrophy and accumulation of GFAP, is a hallmark of all types of central nervous system (CNS) injuries. Potential signaling mechanisms driving the conversion of astrocytes into "reactive" phenotypes differ with respect to the injury models employed and can be complicated by factors such as disruption of the blood-brain barrier (BBB). As denervation tools, neurotoxicants have the advantage of selective targeting of brain regions and cell types, often with sparing of the BBB. Previously, we found that neuroinflammation and activation of the JAK2-STAT3 pathway in astrocytes precedes up regulation of GFAP in the MPTP mouse model of dopaminergic neurotoxicity. Here we show that multiple mechanistically distinct mouse models of neurotoxicity (MPTP, AMP, METH, MDA, MDMA, KA, TMT) engender the same neuroinflammatory and STAT3 activation responses in specific regions of the brain targeted by each neurotoxicant. The STAT3 effects seen for TMT in the mouse could be generalized to the rat, demonstrating cross-species validity for STAT3 activation. Pharmacological antagonists of the neurotoxic effects blocked neuroinflammatory responses, pSTAT3tyr705 and GFAP induction, indicating that damage to neuronal targets instigated astrogliosis. Selective deletion of STAT3 from astrocytes in STAT3 conditional knockout mice markedly attenuated MPTP-induced astrogliosis. Monitoring STAT3 translocation in GFAP-positive cells indicated that effects of MPTP, METH and KA on pSTAT3tyr705 were localized to astrocytes. These findings strongly implicate the STAT3 pathway in astrocytes as a broadly triggered signaling pathway for astrogliosis. We also observed, however, that the acute neuroinflammatory response to the known inflammogen, LPS, can activate STAT3 in CNS tissue without inducing classical signs of astrogliosis. Thus, acute phase neuroinflammatory responses and neurotoxicity-induced astrogliosis both signal through STAT3 but appear to do so through different modules, perhaps localized to different cell types.

Indexed as

AnimalsAstrocytesAza CompoundsBrainCorpus StriatumFemaleGene DeletionGene Expression RegulationGlial Fibrillary Acidic ProteinGliosisHeterocyclic Compounds, 4 or More RingsHippocampusJanus Kinase 2LipopolysaccharidesMaleMiceAza CompoundsCORT 108297Glial Fibrillary Acidic Proteinglial fibrillary astrocytic protein, mouseHeterocyclic Compounds, 4 or More RingsJanus Kinase 2LipopolysaccharidesNerve Tissue ProteinsSTAT3 Transcription Factor

Identifiers

PMID25025494
PMCPMC4098997
OpenAlexW2033215199

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.